In some mice, levels of the liver enzyme alanine aminotransferase (ALT) increased tenfold compared to controls. (sciencedaily.com)
Dopamine did not cause hypertension or affect liver functions (i.e., levels of alanine aminotransferase and aspartate aminotransferase were not elevated, as can happen with currently available anti-VEGF drugs); (sciencedaily.com)
These outcomes were determined by measuring plasma levels of a liver enzyme called alanine aminotransferase (reduced by approximately 55 percent) and levels of liver triglycerides (reduced by approximately 21 percent). (sciencedaily.com)